Dermapharm Holding SE reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EUR 322.87 million compared to EUR 235.72 million a year ago. Net income was EUR 49.4 million compared to EUR 37.37 million a year ago.

Basic earnings per share from continuing operations was EUR 0.92 compared to EUR 0.69 a year ago.